Background: Three Enterococcus isolates obtained from retail chicken collected in 2010-11 as part of the Colombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS) showed reduced susceptibility towards linezolid (MIC 8 mg/L).
Introduction
Linezolid is an oxazolidinone antimicrobial used for treatment of infections with clinically relevant Gram-positive bacteria harbouring resistances, such as MRSA and VRE, and therefore resistance to this drug causes concerns on possible issues in the treatment of enterococcal infections in humans. 1 Resistance in enterococci is mostly mediated by point mutations in the 23S rRNA region and most frequently due to the substitution G2576T and other resistance mechanisms include the plasmid-mediated cfr gene, which is an RNA methylase described by Long et al., 2 which causes modification of the adenine residue at position 2503 in domain V of the 23S rRNA and therefore causes resistance to oxazolidinones, phenicols, lincosamides and streptogramin A. Additionally, cfr(B) was described in Enterococcus faecium isolates from two human patients in New Orleans in 2015. 3 The optrA gene was discovered in enterococci in 2015, from animals and human origin from China. 4 The occurrence of this gene seems not to be limited to the genus Enterococcus as it has been observed also in Staphylococcus sciuri. 5 Similarly, it is not limited to China as it was already observed in Europe in Italy in E. faecium isolates carrying both the cfr and the optrA genes 6 and in two Enterococcus faecalis from Ireland and one from Malaysia. Furthermore, the gene is transferable and has been found on plasmids that harbour resistance to other important antimicrobial classes such as macrolide-lincosamide-streptogramin B, aminoglycoside and phenicols. 5, 8 A recent screening showed that this resistance mechanism is already relatively widespread among pathogenic E. faecalis strains isolated in hospitals in China. 9 In Colombia, a number of studies have focused on understanding the epidemiology of Enterococcus spp. and their associated antimicrobial resistance (AMR) in relation to healthcare-associated infections. 10, 11 However, a comprehensive surveillance on the integrated AMR situation in Colombia did not exist, and the Colombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS) was designed as a pilot programme between 2008 and 2014. This approach included phenotypic and genotypic analysis of two zoonotic pathogens Salmonella spp. and Campylobacter spp., and two indicator organisms: Escherichia coli and Enterococcus spp. from primary animal production systems (poultry, swine and cattle). 12 As a part of a comprehensive survey, samples (n ¼ 1003) recovered from retail stores in 19 regions of Colombia were previously phenotypically characterized, and their antimicrobial susceptibility profiles were determined using automated systems and the disc diffusion method for the complementary antimicrobial targets as chloramphenicol and ceftiofur. 13 Linezolid-resistant E. faecalis isolates were selected based on the MIC and confirmed by three different research centres, CORPOICA, Technical University of Denmark and University of EL Bosque and interpreted using EUCAST epidemiological cut-off (ECOFF) values. Four years after, in light of the new knowledge, it became relevant to perform a new analysis of the genomic data and clarify the origin of the resistance found.
Materials and methods

Strains
A total of 556 enterococci were isolated in 2010-11 in a study performed at the COIPARS and aimed at isolating pathogens and indicator bacteria from retail store meat in 23 Colombian departments. 14 Forty of these isolates were selected for further analysis due to discrepancies observed in the susceptibility testing results and sent to Denmark for further examination in 2011. MICs for the isolates were determined at the National Food Institute in Denmark using broth microdilution on Sensititre panels (TREK, Diagnostic Systems, Westlake, OH, USA). The tests were performed according to CLSI 15, 16 and interpreted using EUCAST ECOFF. Of these, three E. faecalis (12E, 34E and 745E) were selected for WGS due to linezolid resistance phenotype observed with MIC at 8 mg/L.
Additional testing of florfenicol and tedizolid was performed using broth microdilution and MIC determination using gradient diffusion (MIC test strips; Liofilchem, Italy).
PCR screenings
In 2011-12, the three linezolid resistant strains were first screened at CORPOICA in Colombia for the presence of the cfr gene using PCR based on the primers described by Kehrenberg and Schwarz 17 and run conditions as follows: denaturation for 1 min at 94 C, 34 cycles of denaturation for 10 s at 94 C, annealing for 30 s at 48 C, extension for 30 s at 72 C, and a final extension of 7 min at 72 C; as the cfr gene was not detected these strains were submitted to WGS.
An additionally nested PCR, followed by amplicon sequencing of 23S rRNA regions was performed, according to the description by Bourgeois-Nicolaos et al.;
18 however, no relevant point mutations were detected.
After the detection of the optrA gene PCR screening for this gene was attempted in all 40 isolates using the primers described by Wang et al. 4 The same three enterococcal isolates (12E, 34E and 745E) were found positive. The PCR products were purified using the GFX Purification Kit and sequenced at Macrogen Korea as an additional control of the PCR.
DNA preparation and WGS
Genomic DNA was extracted from the three isolates using an Invitrogen Easy-DNA TM Kit (Invitrogen, Carlsbad, CA, USA), and DNA concentrations were determined using the Qubit dsDNA BR assay kit (Invitrogen). The genomic DNA was prepared for Illumina using the Illumina (Illumina, Inc., San Diego, CA, USA) NexteraXT
Guide 150319425031942 following the protocol revision C (http:// support.illumina.com/downloads/nextera_xt_sample_preparation_ guide_15031942.html). Pooled NexteraXT libraries were paired-end sequenced using an Illumina Hiseq platform, according to standard Illumina protocols performed at the Beijing Genomics Institute (BGI). The raw data were trimmed and cleaned for adapters using AdapterRemoval v. 1.1 (https://github.com/slindgreen/AdapterRe moval) before any analysis was performed.
The genomes were assembled using (the reference-guided assembly and de-novo assembly from CLC Bio Genomic Workbench. Raw sequence data have been submitted to the European Nucleotide Archive (http://www.ebi.ac.uk/ena) under sample accession numbers ERS1324259 (12E), ERS1324260 (34E) and ERS1324261 (745E).
Genomic sequence analyses
A search for resistance-associated genes present in the three linezolid resistant isolates was performed using ResFinder after the genomes were obtained in 2011-12. Subsequently, after the optrA gene had been published and included in the ResFinder database in May 2016, the three assembled genomes kept in storage since 2011 were re-analysed. This included re-running of the WGS analyses using the newest version of the analysis tools from the Center for Genomic Epidemiology (CGE), particularly with the ResFinder 2.1 tool, including the optrA gene and variants (https://cge.cbs.dtu.dk/ services/ResFinder/) using default settings. 19 This second analysis of the assembled genomes was enriched using RAST version 2.0, 20 using default parameters, searching for efflux and heavy metal pumps and genes associated with AMR. Furthermore, the isolates were characterized using in silico genomic tools available from the CGE services to confirm species (KmerFinder 2.0 and SpeciesFinder 1. 2 21 ), to detect virulence genes (VirulenceFinder 1. 5 22 ) and the MLST using the MLST 1.8 tool 23 and using the CSI phylogeny 1.2 24 tool for SNP analyses to infer the relatedness of these isolates. All contigs of the strains 12E, 34E and 745E with an average coverage of 100-fold were searched for the pE349 sequence (accession number KP399637) using BLAST analysis with default parameters (http://blast.ncbi.nlm.nih.gov/Blast.cgi). A circular view of optrA in E. faecalis from poultry meat from Colombia JAC the comparative BLAST results was mapped using CGView server (http://stothard.afns.ualberta.ca/cgview_server/). 25 The plasmid sequences identified in the BLAST analysis were automated annotated using Prokka software (http://vicbioinformatics.com/) and annotated sequences aligned and viewed using the MAUVE software tools (http://darlinglab.org/mauve/mauve.html). 26, 27 Global visualization, manual annotation and genetic environment characterization of optrA were performed using Artemis tools (http:// www.sanger.ac.uk/Software/Artemis). The linear representation image of the genetic environment of optrA in the plasmid sequences was realized using DNA Plotter of the Sanger Institute (http:// www.sanger.ac.uk/Software/Artemis/circular/as) from Artemisgenerated files. 28 
Alignment and trees from gene sequence analyses
Sequence analysis of the genes found in the contigs was performed using the CLC Bio DNA Bench program tools. BLAST searches were performed using the National Center for Biotechnology Information website (http://www.ncbi.nlm.nih.gov), using both the blastn and the tbastx algorithms to find the closest match to the found sequences.
All representative sequences of the known optrA genes described were obtained from GenBank in FASTA format. Phylogenetic analysis was conducted using the Neighbour Joining method incorporated in the tools available in CLC bio DNA workbench.
Results
Susceptibility testing, PCR and WGS analyses performed in 2011-12
Only three isolates were confirmed as linezolid resistant with MIC at 8 mg/L when using the Sensititre microbroth dilution method at the Technical University of Denmark. The results of the susceptibility testing of these three isolates as well as the resistance mechanisms, virulence genes and typing results found in the analyses performed in 2016 are shown in Table 1 . Additionally, testing confirmed that all three isolates were also resistant to florfenicol (MIC >256 mg/L) and the MIC of tedizolid were 2 mg/L for isolate 12E and 34E and 1.5 mg/L for isolate 745E.
The PCR screenings performed in 2011 for cfr genes were negative for all isolates. The WGS analyses performed initially did not show resistance genes or mutations that could explain the resistance observed for linezolid. Similarly, the nested PCR amplicons sequenced did not show the expected point mutations conferring resistance to linezolid.
WGS analyses performed in 2016
The species of the three isolates were confirmed as E. faecalis species, but belonging to two different MLST with isolates 12E and 34E being both assigned to ST59 and much closer related to each other than isolate 745E, which was assigned to ST489 and quite distantly related to the others. In addition, the SNP analysis supported these results by showing close relatedness between both isolates obtained from one city (12E and 34E; 61 SNP distant), and distant relatedness to an isolate from meat products purchased in another city (745E; 12242 SNP differences from 12E and 12265 from 34E). All of the isolates harboured AMR genes for tetracyclines [tet(L) and/or tet(K)] macrolides, lincosamides or streptogramins [lnu(B) and/or lsa(A) and/or erm(B)] and phenicol/oxazolidinone (optrA and fexA) and strain 745E additionally harboured aminoglycoside resistance genes [aph(3 0 )-III, aac(6 0 )-apl]. The isolate 745E was additionally resistant to ciprofloxacin, but no plasmid-mediated resistance genes were detected and the data were not additionally screened to detect possible target mutations. Furthermore, other MDR efflux pumps and heavy metal resistance genes, such as copZ, cutC, corC, czcD, czrR, EF-G, TR and CIA, were detected in all three isolates using the RAST server annotations. MIC values that were observed were between 1.5 and 2 mg/L; this is similar to the values observed for E. faecalis E349 and the transformants containing the optrA gene.
The optrA gene regions of the three plasmids showed high similarity to the originally reported optrA-carrying plasmid pE349 (Figure 1a) . The optrA upstream and downstream regions were virtually indistinguishable in the three plasmids pE_12, pE_34 and pE_745 and the optrA-carrying plasmid pE349 reported by Wang et al. 4 ( Figure 1b ). DNA sequences of the optrA gene of the three Colombian strains were compared with the available optrA sequences. All three isolates carry variants of the optrA gene, which are <2% distant from previously found optrA sequences. In the case of strains 12E and 745E these isolates both carry an optrA gene identical to the one found in strain E016 isolated in China in the study by He et al.
8 (2016), whereas strain 34E carries an optrA gene with a slightly different nucleotide sequence that is more closely related to the optrA found in Italy in an E. faecium strain and described in 2016 by Brenciani et al. 6 Interestingly one of the isolates originating from the urine of a female human patient in China, from the study of Cai et al., 9 was of the same MLST, ST59, as 12E and 34E.
Discussion
In this study, we present the first known report of the presence of the optrA gene in the American continent in E. faecalis isolated from raw meat of poultry origin. The results show that these isolates obtained from retail meat harboured genes encoding resistance to important drug classes that are likely found on mobile genetic elements and could eventually be transferred to other strains or species and spread relatively easily. The results showed the presence of a number of virulence genes, which is in agreement with recent studies showing a high prevalence of virulence factors in E. faecalis of food origin; 29 in addition, the presence of different families of efflux pumps and the ability of these bacteria to increase AMR and virulence is concerning. 30 However, the interpretation of these findings is not straightforward and further screenings in animal and human pathogenic strains are required to ascertain the importance of linezolid resistance determined by optrA genes in pathogenic strains.
It is noteworthy that even though during the first analysis round in 2012 it was not possible to identify the mechanism of resistance present in the isolates, it was possible to get back to the data stored at a later stage and re-analyse the data 4 years later, and following the discovery of the optrA resistance gene in China. 4 It is possible to use the stored data and rapidly perform screenings to find the most recently discovered resistance gene and link it to the phenotype observed. 19, 31 Such results give a good example and an incentive for continuous improvement of genomic tools and show the usefulness of storing and sharing the raw genomic data. 32 WGS allows the integration of national, regional and global surveillance metadata of pathogens. 33 The genomic epidemiology web tools are freely available and supported by the Technical University of Denmark and open up possibilities to fast analysis and a variety of results from the local and global AMR-WGS data. These approaches could foster initiatives to capture essential information on the global situation of AMR.
Recent experience with the detection of newly discovered resistance has shown that these genes and the mobile elements that harbour them are likely to be more widespread than first thought and this has been well demonstrated by the findings related to the mcr-1 gene, which were reported shortly after it was described in China, 34 with findings in Europe obtained using already available WGS data 35 and quite rapidly detected all over the world. 36 Therefore, we might think that this observation of optrA in Gram-positives in China, 4 other parts of Asia and Europe 6, 7 and now in South America might indicate a similar phenomenon, which is of great importance because optrA confers resistance to linezolid, which is one of the last-resource antimicrobials used for treatment of humans with infections caused by multiresistant Gram-positive strains. We have shown that this resistance gene is much more widespread than first thought and is probably associated with a successful plasmid that allows it to spread easily.
Conclusions
To the best of our knowledge, this is the first time that optrA is found in the American Continent, since it was first described in China and was observed in isolates from Malaysia and additionally observed in Europe.
Even though the clinical implications are still relatively unknown, the spread of optrA encoding linezolid and phenicol resistance is concerning and screenings in Gram-positive isolates from food, animal and human origin are recommended.
